Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply

B. Christensen, P. R. Gibson, D. T. Rubin

Research output: Contribution to journalLetterOtherpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1423-1424
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Volume47
Issue number10
DOIs
Publication statusPublished - May 2018

Cite this